Viewing nowEmpagliflozin 25 mg (Empagliflozin)
Empagliflozin 25mg
Tablet · Prescription medication
Samcheondang Pharmaceutical Co., Ltd.

MFDS item code 202102076 · Approved 2021.03.05 · Insurance code 651206180
Improvement of glycemic control in adults with type 2 diabetes mellitus
This drug is used in conjunction with diet and exercise therapy to help control blood sugar in adult patients with type 2 diabetes. It can be used as monotherapy and, if blood sugar control is insufficient, can be combined with metformin, pioglitazone, sulfonylureas, or insulin. It can also be used in combination with the DPP-4 inhibitor linagliptin. Special caution is necessary for patients with type 2 diabetes who have cardiovascular disease regarding the occurrence of cardiovascular events. Overall, this drug is used to improve blood sugar control effects in conjunction with various treatment options.
The recommended dose of this medicine is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. No dose adjustment is required for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistent glomerular filtration rate < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. No dose adjustment is required for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients 75 years of age and older. Initiation of this medicine is not recommended in patients 85 years of age and older because clinical experience is limited
This drug should not be used in patients who are allergic to the active ingredient or any components. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. This drug is not to be used in patients with severely impaired kidney function, end-stage renal disease, or those on dialysis. This drug contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. Patients with mildly impaired kidney function require dosage adjustment, and if kidney function worsens, administration should be discontinued. Due to the expected lack of efficacy in end-stage renal disease or dialysis patients, this drug should not be used in these groups. Mild cases in patients with heart failure should use this medication cautiously, while it is not advisable for severe cases. When used with insulin or insulin secretagogues, there may be a risk of hypoglycemia, so dosage adjustments may be necessary. During treatment with this drug, side effects such as hypoglycemia, infections, and increased urination may occur, so symptoms should be monitored. Particularly for women, genital infections may occur more frequently, and immediate treatment is needed if symptoms develop. There may be a reduction in fluid volume or blood pressure, so caution is advised for the elderly or those with low blood pressure. Serious side effects, such as liver dysfunction or ketoacidosis, have been reported, so if symptoms occur, immediate consultation with a healthcare professional is necessary. This drug may have a mild effect when driving or operating machinery, so caution is required, especially in cases with a risk of hypoglycemia. It is recommended that pregnant or nursing women avoid this drug and discontinue use if pregnancy is confirmed. Safety and efficacy in children under 18 years of age have not been established, so it is not to be used in this population. No specific toxic symptoms have been reported in cases of overdose, but in the event of an overdose, immediate healthcare consultation is advised to receive appropriate treatment. This drug should be stored out of reach of children, and it is safe not to transfer it to another container. Regular kidney function tests are essential during the use of this drug, and any abnormal symptoms should be discussed with a healthcare professional immediately.
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it should be stored in a sealed container. It is advisable to maintain a room temperature between 1 and 30 degrees Celsius for storage. Storing it this way helps to safely preserve the drug's efficacy.
Pale yellow, round, biconvex, film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEmpagliflozin 25mg
Tablet · Prescription medication
Samcheondang Pharmaceutical Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Korea Prime Pharmaceuticals Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.